Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Boehringer Ingelheim presents novel MPGES-1 inhibitors

July 9, 2012

New candidate cancer therapeutics designed at CSIR

July 9, 2012

Novel FPR2/ALX receptor agonists divulged by Actelion Pharmaceuticals

July 9, 2012

Siena Biotech patents new SMO receptor antagonists

July 9, 2012

Researchers at Piramal Life Sciences prepare new PI3Kalpha inhibitors

July 9, 2012

Epizyme synthesizes novel DOT1-like protein inhibitors

July 6, 2012

U.S. university patents new polypeptides

July 6, 2012

Chinese group reports new antivirals

July 6, 2012

Roche divulges novel Mdm2/p53 interaction inhibitors

July 6, 2012

Italian researchers disclose novel EP4 receptor antagonists

July 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...